Pleural Irrigation with a Novel Device for Pleural Effusion
This study is testing a new way to treat retained pleural effusion (fluid buildup around the lungs) using a device called the CLR™ irrigator. This device helps deliver saline (saltwater) directly into the chest cavity. You might be able to join if you have retained pleural effusion after a chest tube insertion and cannot receive standard enzyme therapy. The researchers want to see if this irrigation method can reduce the amount of fluid around your lungs, measured daily by ultrasound for 8 days. The study plans to enroll 10 participants, but its current status is unclear.
- Study design
- This is a single-arm pilot study, meaning all 10 participants will receive the same intervention. It is designed to test the use of intrapleural saline irrigation.
- What's involved
- Participants will have a CLR™ port and CLR™ irrigator added to their chest tube and atrium circuit. Radiographic improvement will be measured daily by bedside ultrasound for 8 days.
- Compensation
- Not stated in the trial record.
- Follow-up
- Radiographic improvement will be measured daily for 8 days.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Pleural Irrigation With a Novel Devise.
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Radiographic improvement (reduction in the ammount of pleural effusion messured in centimeters) by bed side ultrasound day 1,2,3,4,5.Daily for 8 days